{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:10:50Z","timestamp":1791259850328,"version":"4.1.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T00:00:00Z","timestamp":1598140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008604","name":"Scleroderma and Raynaud\u2019s UK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008604","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Royal Free Charity"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To investigate the association between proton pump inhibitor (PPI) use and the presence and severity of calcinosis in SSc.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We analysed data from two SSc cohorts from a single centre. Cohort 1 included 199 patients reviewed over 10\u2009years, for whom retrospective data on PPI use and calcinosis were available. Cohort 2 was recruited prospectively and included 215 consecutive patients, who underwent clinical assessment. Outcomes of interest were presence of current calcinosis (CC) or calcinosis at any time (CAT).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The cohort 1 data analysis showed that among patients on standard dose PPI 20% had calcinosis, while in those on high doses of PPI calcinosis was present in 39% (P\u2009=\u20090.003). Analysis of the data from cohort 2 confirmed these findings, demonstrating that the odds of CAT increased significantly with longer PPI exposure [odds ratio (OR) 1.04, 95% CI: 1.02, 1.06; P\u2009&amp;lt;\u20090.001], longer disease duration (OR 1.08, 95% CI: 1.05, 1.12; P\u2009&amp;lt;\u20090.001) and greater age (OR 1.03, CI: 1.01, 1.05; P\u2009=\u20090.010). Multivariable logistic regression showed that higher exposure to PPI remained a significant predictor of calcinosis, with PPI exposure &amp;gt;10\u2009years increasing the risk of CAT &amp;gt;6-fold, compared with no PPI (OR 6.37, 95% CI: 1.92, 21.17; P\u2009=\u20090.003) after adjusting for disease duration and antibodies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We confirm a significant association between high PPI exposure with severity of calcinosis in SSc. Given the clinical impact of calcinosis and reflux in SSc, PPI exposure as a potentially modifiable risk factor for calcinosis requires further evaluation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa332","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T11:38:58Z","timestamp":1591961938000},"page":"849-854","source":"Crossref","is-referenced-by-count":18,"title":["High proton pump inhibitor exposure increases risk of calcinosis in systemic sclerosis"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3480-7251","authenticated-orcid":false,"given":"Lauren V","family":"Host","sequence":"first","affiliation":[{"name":"Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, Royal Free Campus, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6806-3794","authenticated-orcid":false,"given":"Corrado","family":"Campochiaro","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, Royal Free Campus, London, UK"},{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UniRAR), San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0297-694X","authenticated-orcid":false,"given":"Ana","family":"Afonso","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, Royal Free Campus, London, UK"},{"name":"Internal Medicine Department, Hospital Pedro Hispano, Matosinhos, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5178-9038","authenticated-orcid":false,"given":"Svetlana I","family":"Nihtyanova","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, Royal Free Campus, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3975-8938","authenticated-orcid":false,"given":"Christopher P","family":"Denton","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, Royal Free Campus, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5474-0053","authenticated-orcid":false,"given":"Voon H","family":"Ong","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, Royal Free Campus, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,23]]},"reference":[{"key":"2021020119071723800_keaa332-B1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.mayocp.2017.10.022","article-title":"Proton pump inhibitors: review of emerging concerns","volume":"93","author":"Nehra","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"2021020119071723800_keaa332-B2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5009\/gnl15502","article-title":"25 years of proton pump inhibitors: a comprehensive review","volume":"11","author":"Strand","year":"2017","journal-title":"Gut Liver"},{"key":"2021020119071723800_keaa332-B3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40801-016-0067-4","article-title":"Drug-induced subacute cutaneous lupus erythematosus associated with proton pump inhibitors","volume":"3","author":"Aggarwal","year":"2016","journal-title":"Drugs Real World Outcomes"},{"key":"2021020119071723800_keaa332-B4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s40264-013-0062-6","article-title":"Long-term proton pump inhibitor use is associated with vascular calcification in chronic kidney disease: a cross-sectional study using propensity score analysis","volume":"36","author":"Fusaro","year":"2013","journal-title":"Drug Saf"},{"key":"2021020119071723800_keaa332-B5","first-page":"1","article-title":"Proton pump inhibitors and risk of calcium pyrophosphate deposition (CPPD) in a population-based study. 2018 ACR\/ARHP Annual Meeting Abstract Supplement","volume":"70(Suppl 10","author":"Neogi","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2021020119071723800_keaa332-B6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5301\/jsrd.5000214","article-title":"Gastrointestinal manifestations of systemic sclerosis","volume":"1","author":"Shreiner","year":"2016","journal-title":"J Scleroderma Relat Disord"},{"key":"2021020119071723800_keaa332-B7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/14397595.2017.1349594","article-title":"Are there risk factors for scleroderma-related calcinosis?","volume":"28","author":"Pai","year":"2018","journal-title":"Mod Rheumatol"},{"key":"2021020119071723800_keaa332-B8","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1093\/rheumatology\/kew193","article-title":"Calcinosis in systemic sclerosis: subsets, distribution and complications","volume":"55","author":"Bartoli","year":"2016","journal-title":"Rheumatology (Oxford"},{"key":"2021020119071723800_keaa332-B9","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/rheumatology\/kew313","article-title":"Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study","volume":"55","author":"Baron","year":"2016","journal-title":"Rheumatology (Oxford"},{"key":"2021020119071723800_keaa332-B10","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/BOR.0000000000000539","article-title":"Calcinosis in scleroderma","volume":"30","author":"Valenzuela","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"2021020119071723800_keaa332-B11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.semarthrit.2005.01.016","article-title":"Calcinosis in rheumatic diseases","volume":"34","author":"Boulman","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"2021020119071723800_keaa332-B12"},{"key":"2021020119071723800_keaa332-B13","doi-asserted-by":"crossref","first-page":"e0199160","DOI":"10.1371\/journal.pone.0199160","article-title":"Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis","volume":"13","author":"Okamoto","year":"2018","journal-title":"PLoS One"},{"key":"2021020119071723800_keaa332-B14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10522-016-9675-3","article-title":"Different transcriptional profiling between senescent and non-senescent human coronary artery endothelial cells (HCAECs) by omeprazole and lansoprazole treatment","volume":"18","author":"Costarelli","year":"2017","journal-title":"Biogerontology"},{"key":"2021020119071723800_keaa332-B15","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1161\/CIRCRESAHA.116.308807","article-title":"Proton pump inhibitors accelerate endothelial senescence","volume":"118","author":"Yepuri","year":"2016","journal-title":"Circ Res"},{"key":"2021020119071723800_keaa332-B16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF02207673","article-title":"Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis","volume":"14","author":"Di Munno","year":"1995","journal-title":"Clin Rheumatol"},{"key":"2021020119071723800_keaa332-B17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.semarthrit.2016.05.008","article-title":"Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: a scleroderma clinical trials consortium study","volume":"46","author":"Valenzuela","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"2021020119071723800_keaa332-B18","first-page":"S.912","article-title":"Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis","volume":"56","author":"Bissell","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"2021020119071723800_keaa332-B19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.semarthrit.2010.03.002","article-title":"Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence","volume":"40","author":"Christmann","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"2021020119071723800_keaa332-B20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/acr.22434","article-title":"Validation of a novel radiographic scoring system for calcinosis affecting the hands of patients with systemic sclerosis","volume":"67","author":"Chung","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/2\/849\/36167765\/keaa332.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/2\/849\/36167765\/keaa332.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T03:52:46Z","timestamp":1612324366000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/2\/849\/5896153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,23]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,8,23]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa332","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,8,23]]}}}